Key Metrics
Company Snapshot
Scale AI is based in San Francisco, United States, founded 2016 by Lucy Guo. Latest valuation $29B (As of Jul 20, 2026, Value Add VC entity registry).
Recent changes
- Sep 24, 2026Sep 24, 2026BigHat Biosciences Raises $75M To Scale AI Antibody Design Pulse story
- Sep 15, 2026Sep 15, 2026Inspiren Raises $70M To Scale AI Senior-Living Platform Pulse story
- Sep 13, 2026Sep 13, 2026Qupital Raises $300M To Scale AI Trade-Finance Underwriting Pulse story
- Jul 20, 2026Jul 20, 2026Valuation rose from ~$29B to $29B entity-registry reconciliation
- Jun 26, 2026Jun 26, 2026Quantifind Raises $200M to Scale AI Risk Intelligence for Banks and National Security Pulse story
Earlier changes (3)
- Jun 17, 2026Jun 17, 2026Behavox Raises $175M in Growth Equity to Scale AI Compliance Pulse story
- Jun 2025Jun 2025First reported valuation: ~$29BEstimated TechCrunch — Meta invests in Scale, Wang leaves (June 2025)
- 20252025First reported revenue: ~$870M (~$2B projected for 2025)Estimated TechCrunch — Meta invests in Scale, Wang leaves (June 2025)
Underlying values
| As of | Value | Method | Source |
|---|---|---|---|
| Jul 20, 2026 | $29B | Reported | Value Add VC entity registry |
| Jun 2025 | ~$29B (Meta investment, June 2025) | Estimated | TechCrunch — Meta invests in Scale, Wang leaves (June 2025) |
| Jun 2025 | ~$29B | Estimated | TechCrunch — Meta invests in Scale, Wang leaves (June 2025) |
Investors
Latest Pulse
- Sep 24, 2026BigHat Biosciences Raises $75M To Scale AI Antibody DesignBigHat Biosciences closed a $75 million Series C co-led by DFJ Growth and Premji Invest, taking total funding to $223 million as its AI-designed antibody-drug conjugate enters a Phase 1 trial for gastric cancer.→
- Sep 24, 2026Why AI Deals Are Repricing In Months, Not YearsFour venture-backed companies repriced at two to five times their own prior valuation marks in six weeks, and only one of them trains foundation models -- evidence investors are underwriting growth speed broadly, not just an AI-label premium.→
- Sep 22, 2026Snorkel AI Raises $350M, Triples Valuation To $3.5BSnorkel AI raised a $350 million Series E co-led by Insight Partners and Section 32 at a $3.5 billion valuation, nearly triple its mark from 17 months ago, as its data-as-a-service revenue run rate crossed $375 million.→
- Sep 21, 2026Corridor Raises $25M To Rebuild SMB Health BenefitsCorridor raised a $25 million seed round led by Bain Capital Ventures to build an AI-native health insurance brokerage for businesses with 1 to 100 employees, a segment traditional brokers often deprioritize.→
- Sep 15, 2026Inspiren Raises $70M To Scale AI Senior-Living PlatformInspiren raised $70 million in a Series C round valuing the ambient-sensor senior-living startup above $500 million, its largest round yet as it expands an AI platform that predicts falls before they happen.→
- Sep 14, 2026Hundreds Of OpenAI Contractors Are Reading Your ChatGPT ChatsOpenAI runs an internal effort called Project Lily in which hundreds of contractors read and grade real ChatGPT conversations to tune the model's tone, and sensitive user details sometimes survive redaction.→
- Sep 13, 2026Qupital Raises $300M To Scale AI Trade-Finance UnderwritingHong Kong fintech Qupital raised $300 million in combined Series C equity and asset-backed financing led by M Capital with MUFG participation, pushing cumulative loans processed past $9.5 billion as it eyes an IPO.→
- Sep 10, 2026Alibaba, Tencent Back UniPat AI At $2.5BAlibaba is leading a $300 million investment in UniPat AI, an AI model-testing and benchmarking startup founded by a former Alibaba intern, valuing the company at $2.5 billion with Tencent also participating.→
- Sep 8, 2026Meta Bets Its AI Agent Muse Can Catch UpMeta launched Muse, a personal AI agent that can email, shop, book travel and manage smart-home devices on a user's behalf, its first consumer product from Meta Superintelligence Labs since Llama 4's reception fell short of rivals.→
- Sep 4, 2026XDOF Nears $1.2B Valuation Three Months Out of StealthThe robot training-data startup is in late-stage talks for a Series B led by 8VC, roughly three months after a $70 million Series A and with annualized revenue approaching $50 million.→
Value Add Research
- AI & Technology · Aug 1, 2026$29B Scale AI — Valuation After the Meta Deal (2026)
- AI & Technology · Jul 19, 2026Scale AI: Meta Paid $14.3B, Now Guiding to Just $1B
- AI & Technology · Sep 9, 2026XDOF Valuation 2026: $1.2B Series B Talks, 3 Months Out of Stealth
- AI & Technology · Sep 6, 2026Conveo Raises $50M Series A From DST Global for AI Research
- AI & Technology · Aug 28, 2026Stripe OpenRouter Acquisition: $8B Price, 6x Valuation Jump, and What It Buys
- AI & Technology · Aug 22, 2026Nvidia's $7B Poolside Deal: The Reverse Acquihire Playbook
- AI & Technology · Jul 19, 2026Mercor's $2B ARR Is Really Closer to $600M Net
- AI & Technology · Jul 11, 2026$10B+: The 10 Highest-Valued Private AI Companies in 2026
Related Companies
Trace's Take
Meta's ~$14B for half of Scale was really an aqui-hire of Alexandr Wang plus an insurance policy on data supply — and it quietly handed Scale's biggest gift to its competitors. Every rival lab now has a reason to move spend to Surge or Mercor rather than fund a Meta affiliate. The lesson for founders: a strategic at 49% can be worth more in cash than control, but it can also strand the rest of your market. Watch whether Scale's revenue holds as labs diversify away.
How Scale AI makes money
Scale sells the training and evaluation data that frontier AI runs on — human labeling, RLHF (reinforcement learning from human feedback), red-teaming, and model evaluation — to the major AI labs and enterprises, plus a growing government and defense business and an applications arm.
The Meta deal reshaped the company: by taking ~49% and hiring away founder Alexandr Wang, Meta secured priority access to Scale's data pipeline, while rival labs now weigh whether to keep buying from a Meta-aligned vendor. That tension — neutral data foundry vs. Meta affiliate — is the defining question for Scale's next chapter.
Competitors
- Surge AI — The largest pure-play data rival, now benefiting from Scale's Meta entanglement.
- Mercor — Expert-marketplace model; Scale sued it over trade secrets.
- Labelbox — Enterprise annotation platform.
- Turing / Micro1 — Talent-driven data and evaluation.
Profile sources (verified 2026-06-28): TechCrunch — Meta invests in Scale, Wang leaves (June 2025) · Fortune — Meta/Scale/Wang (June 2025)
Scale AI FAQ
Does Meta own Scale AI?
Meta took a roughly 49% non-voting stake in Scale AI in June 2025 for about $14.3 billion, valuing Scale at around $29 billion. Meta has no voting control, and founder Alexandr Wang left to join Meta while remaining on Scale's board.
How does Scale AI make money?
Scale sells training and evaluation data to AI labs and enterprises — human labeling, RLHF, red-teaming, and model evaluation — plus government/defense contracts and an applications business.
What is Scale AI's revenue?
Scale reported roughly $870 million in revenue for 2024, with 2025 projected to reach about $2 billion (a projection, not audited results).
What is Scale AI's valuation?
Scale AI's valuation is $29B (As of Jul 20, 2026, Value Add VC entity registry).
Who are Scale AI's investors?
Scale AI's investors include Spark Capital (As of Jul 20, 2026).
Sources & methodologyshow
- TechCrunch — Meta invests in Scale, Wang leaves (June 2025)major outlet1 fact
- Value Add VC entity registryunspecified source1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.